Its about breathing easier, having more energy, sleeping better, and feeling more confident in your everyday life
Because MTC remains extremely rare, detecting small risk changes can be challenging
A new Australian meta-analysis of more than 85,000 patients, including those with and without diabetes, found GLP-1 receptor agonists reduced the risk of kidney failure by 16%, and the worsening of kidney function by 22%
Foundayos advantage is everyday simplicity with no fasting, no water cap, no timing rules, which for many people is what makes a daily medicine stick
Structuring the future of metabolic medicine requires both systemic lifestyle protocols and rapid, non-toxic clinical execution